Clinical Trial Update: Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery [Phase 2]

View source ↗

Summary

Phase II study evaluating safety and efficacy of OTX-DP for ocular inflammation and pain after cataract surgery has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation
• Pain After Cataract Surgery

Drugs mentioned

• OTX-DP

Snippet

Sponsor: Ocular Therapeutix, Inc. | Conditions: Ocular Inflammation and Pain | Phase 2 | Status: COMPLETED | Results posted: 2017-04-27